Helicobacter pylori infection promotes the progression of gastric cancer by regulating the expression of DMBT1

Table 5 Comparison of relative invasive capacities in each group

Group	mean ± SD	vs group	95%CI	F	η2
Control	39.20 ± 4.00b,c,d	H. pylori	-49.44 to -34.16	514.75	0.990
		si-DMBT1	-90.04 to -74.76
		H. pylori + si-DMBT1	-143.04 to -127.76
H. pylori	81.00 ± 3.54a,c,d	si-DMBT1	-48.24 to -32.96
		H. pylori + si-DMBT1	-101.24 to -85.96
si-DMBT1	121.60 ± 5.23a,b,d	H. pylori + si-DMBT1	-60.64 to -45.36
H. pylori + si-DMBT1	174.60 ± 8.62a,b,c

^aP < 0.05 vs control group.

^bP < 0.05 vs Helicobacter pylori group.

^cP < 0.05 vs si-DMBT1 group.

^dP < 0.05 vs Helicobacter pylori + si-DMBT1 group.

H. pylori: Helicobacter pylori; DMBT1: Deleted in malignant brain tumors 1; CI: Confidence interval.